SCHEMBL10151906

SCHEMBL10151906

CC1(C)CC2CC1C1CCCCC21

nearest known ligand 0.41

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.41
GAA P10253 1/20 0.41
MAPT P10636 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18636837 0.95 ALDH1A1 (0.44) ALDH1A1GAAMAPT
SCHEMBL13758456 0.75 GPBAR1 (0.33)
SCHEMBL19303433 0.74 ALDH1A1 (0.42) ALDH1A1GAAMAPT
SCHEMBL22600520 0.74 ALDH1A1 (0.42) ALDH1A1GAAMAPT
SCHEMBL22268519 0.74 ALDH1A1 (0.42) ALDH1A1GAAMAPT
SCHEMBL24760392 0.74 ALDH1A1 (0.42) ALDH1A1GAAMAPT
SCHEMBL7625098 0.74 ALDH1A1 (0.42) ALDH1A1GAAMAPT
SCHEMBL20000745 0.74 ALDH1A1 (0.42) ALDH1A1GAAMAPT
SCHEMBL12325007 0.71
SCHEMBL12389974 0.71 ALDH1A1 (0.40) ALDH1A1GAAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120040294-A1 Top Coating Composition CENTRAL GLASS COMPANY, LIMITED (JP) 2012-02-16 US disclosed
US-7887990-B2 Fluorine-containing compound, fluorine-containing polymer, postive-type resist composition, and patterning process using same CENTRAL GLASS COMPANY, LIMITED (JP) 2011-02-15 US disclosed
US-20080311507-A1 Fluorine-Containing Compound, Fluorine-Containing Polymer, Postive-Type Resist Composition, And Patterning Process Using Same CENTRAL GLASS COMPANY, LIMITED (JP) 2008-12-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080311507-A1 Fluorine-Containing Compound, Fluorine-Containing Polymer, Postive-Type Resist Composition, And Patterning Process Using Same FRG1, FBXL19, FEM1B ALDH1A1 2430/4885GAA 4431/4885MAPT 2426/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.